January/February #185 : HIV, Meds and Booze - by Benjamin Ryan

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents


Heart to Heart

Myths of Black MSM

From the Editor

Sowing the Seeds of Love


Letters-January/February 2013


Standing Against Stigma

POZ Planet

Storm Troopers

Say What-Fran Lebowitz

Oh No Canada

Signs of the Times

For Your Consideration...

Climb Every Mountain

Grindr IQ

Care and Treatment

Using Condoms As Directed

English Lessons

Comprehensive Care Is Possible

HIV, Meds and Booze

Research Notes

Cure: HDAC Inhibitors May Need Combos

Prevention: Revisiting HIV in Semen

Treatment: New Fusion Inhibitor, Integrase Inhibitor

POZ Survey Says

Full Disclosure

POZ Heroes

Minister of HIV

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

email print

January / February 2013

HIV, Meds and Booze

by Benjamin Ryan

Alcohol itself doesn’t have a detrimental effect on CD4 cell counts for people taking antiretroviral (ARV) therapy, a recent study concludes. But this isn’t a simple carte blanche to drink up, say its authors, as well as other experts on the topic of substance use within the HIV population.

“Among all the factors that affect non-adherence to medications, alcohol is the most robust,” said Seth Kalichman, a professor of psychology at the University of Connecticut and the lead author of a related study. Looking at people with HIV who are taking ARVs and who also drink alcohol, he found that half of them purposefully skipped their medications when drinking.

Previous research has documented that alcohol’s disorienting effects significantly lower adherence rates. It has also uncovered that a majority of people living with HIV in the United States falsely believe that ARVs and booze are a harmful mix—a notion that essentially amounts to a wives’ tale. (Important exceptions are those coinfected with hepatitis B or C, for whom any alcohol consumption is highly toxic to the liver.)

Participants in Kalichman’s study who held these erroneous beliefs about toxicity were more likely to skip or stop their HIV meds while drinking. What’s more, they were less likely to maintain an undetectable viral load and more likely to have a CD4 count below 200.

Kalichman said that health care providers urgently need to intervene and challenge these misconceptions among their patients.

Search: alcohol, antiretroviral therapy, Seth Kalichman, University of Connecticut, skipping meds

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Hide comments

Previous Comments:


[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Has a pet helped you deal with your HIV?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.